The Discounted Cash Flow (DCF) valuation of Chunghwa Chemical Synthesis & Biotech Co Ltd (1762.TW) is 20.97 TWD. With the latest stock price at 28.45 TWD, the upside of Chunghwa Chemical Synthesis & Biotech Co Ltd based on DCF is -26.3%.
Based on the latest price of 28.45 TWD and our DCF valuation, Chunghwa Chemical Synthesis & Biotech Co Ltd (1762.TW) is a sell. selling 1762.TW stocks now will result in a potential gain of 26.3%.
| Range | Selected | |
| WACC / Discount Rate | 5.5% - 12.3% | 8.9% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 11.37 - 85.40 | 20.97 |
| Upside | -60.0% - 200.2% | -26.3% |